Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
Doximity Inc (NYSE: DOCS) closed the day trading at $61.0 up 2.73% from the previous closing price of $59.38. In other words, the price has increased by $2.73 from its previous closing price. On the day, 1.54 million shares were traded. DOCS stock price reached its highest trading level at $61.47 during the session, while it also had its lowest trading level at $59.75.
Ratios:
For a better understanding of DOCS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.49 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 42.86. For the most recent quarter (mrq), Quick Ratio is recorded 6.92 and its Current Ratio is at 6.92. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On June 02, 2025, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $80.
Piper Sandler Upgraded its Neutral to Overweight on February 07, 2025, whereas the target price for the stock was revised from $31 to $78.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 11 ’25 when Benjamin Regina M. sold 5,000 shares for $60.04 per share. The transaction valued at 300,200 led to the insider holds 16,618 shares of the business.
REGINA M BENJAMIN bought 5,000 shares of DOCS for $300,200 on Jul 11 ’25. On Jul 01 ’25, another insider, Wampler Kira Scherer, who serves as the Director of the company, sold 2,000 shares for $60.96 each. As a result, the insider received 121,920 and left with 16,618 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DOCS now has a Market Capitalization of 11432436736 and an Enterprise Value of 10554127360. As of this moment, Doximity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 55.08, and their Forward P/E ratio for the next fiscal year is 38.85. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 7.26. For the stock, the TTM Price-to-Sale (P/S) ratio is 20.04 while its Price-to-Book (P/B) ratio in mrq is 10.64. Its current Enterprise Value per Revenue stands at 18.503 whereas that against EBITDA is 44.789.
Stock Price History:
The Beta on a monthly basis for DOCS is 1.36, which has changed by 1.1770165 over the last 52 weeks, in comparison to a change of 0.17774606 over the same period for the S&P500. Over the past 52 weeks, DOCS has reached a high of $85.21, while it has fallen to a 52-week low of $25.00. The 50-Day Moving Average of the stock is 5.74%, while the 200-Day Moving Average is calculated to be 8.27%.
Shares Statistics:
Over the past 3-months, DOCS traded about 2.38M shares per day on average, while over the past 10 days, DOCS traded about 1551580 shares per day. A total of 137.78M shares are outstanding, with a floating share count of 132.36M. Insiders hold about 29.38% of the company’s shares, while institutions hold 67.73% stake in the company. Shares short for DOCS as of 1751241600 were 5750839 with a Short Ratio of 2.41, compared to 1748563200 on 4902438. Therefore, it implies a Short% of Shares Outstanding of 5750839 and a Short% of Float of 4.32.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Currently, 16.0 analysts are dedicated to thoroughly evaluating and rating the performance of Doximity Inc (DOCS) in the stock market.The consensus estimate for the next quarter is $0.35, with high estimates of $0.45 and low estimates of $0.3.
Analysts are recommending an EPS of between $1.86 and $1.3 for the fiscal current year, implying an average EPS of $1.45. EPS for the following year is $1.61, with 17.0 analysts recommending between $2.13 and $1.46.
Revenue Estimates
17 analysts predict $139.54M in revenue for the current quarter. It ranges from a high estimate of $140.06M to a low estimate of $139M. As of the current estimate, Doximity Inc’s year-ago sales were $126.68MFor the next quarter, 17 analysts are estimating revenue of $150.26M. There is a high estimate of $155.3M for the next quarter, whereas the lowest estimate is $145.32M.
A total of 19 analysts have provided revenue estimates for DOCS’s current fiscal year. The highest revenue estimate was $630.29M, while the lowest revenue estimate was $622.7M, resulting in an average revenue estimate of $626.25M. In the same quarter a year ago, actual revenue was $570.4MBased on 19 analysts’ estimates, the company’s revenue will be $691.9M in the next fiscal year. The high estimate is $712.23M and the low estimate is $675.2M.
